Christina Lake Cannabis Corp. Stock Other OTC
Equities
CLCFF
CA17104U1021
Pharmaceuticals
Sales 2022 | 10.07 13.73 | Sales 2023 | 11.78 16.05 | Capitalization | 3.93M 5.36M |
---|---|---|---|---|---|
Net income 2022 | -2M -2.73M | Net income 2023 | -4M -5.45M | EV / Sales 2022 | 1,756,705 x |
Net Debt 2022 | 4.61M 6.28M | Net Debt 2023 | 4.68M 6.38M | EV / Sales 2023 | 731,575 x |
P/E ratio 2022 |
-6.19
x | P/E ratio 2023 |
-0.95
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.41% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Aiken
CEO | Chief Executive Officer | - | 22-09-15 |
Ryan Smith
DFI | Director of Finance/CFO | - | 20-02-29 |
Salvatore Milia
CTO | Chief Tech/Sci/R&D Officer | - | 21-03-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gil Playford
BRD | Director/Board Member | 75 | 20-12-15 |
Joel Dumaresq
BRD | Director/Board Member | 60 | 18-01-31 |
James McMillan
CHM | Chairman | - | 22-03-14 |
1st Jan change | Capi. | |
---|---|---|
+3.99% | 3.12B | |
+99.71% | 1.88B | |
+90.48% | 64.64M | |
+300.00% | 58.35M |